DMKJ
XFOR icon

David M. Knott Jr’s X4 Pharmaceuticals XFOR Stock Holding History

David M. Knott Jr’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,136
Closed -$113K – 100
2024
Q4 		$113K Hold
5,136
– – 0.04% 58
2024
Q3 		$103K Sell
5,136
-897
-15% -$18.7K 0.04% 66
2024
Q2 		$105K Hold
6,033
– – 0.04% 68
2024
Q1 		$252K Buy
6,033
+2,056
+52% +$57.2K 0.09% 62
2023
Q4 		$100K Buy
+3,977
New +$96.7K 0.04% 63

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

David M. Knott Jr's XFOR Position: Q1 2025 in Review

David M. Knott Jr sold out of X4 Pharmaceuticals (XFOR) in Q1 2025, closing a stake of 5,136 shares — an estimated $113K sold.

David M. Knott Jr first reported a position in XFOR in Q4 2023 and held it in 5 quarters. The position peaked at $252K in Q1 2024. 93 funds tracked by Wall St. Rank hold XFOR as of Q1 2025.

  • David M. Knott Jr reported no remaining X4 Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • David M. Knott Jr sold 5,136 X4 Pharmaceuticals shares in Q1 2025, an estimated $113K.
  • David M. Knott Jr first reported a position in X4 Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • David M. Knott Jr's X4 Pharmaceuticals position peaked at $252K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2025.

Based on David M. Knott Jr's 13F filing for Q1 2025, filed 12 May 2025.